ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      85.325
      0.25%
      Bitcoin
      63,307.91
      1.02%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Ferrex (FRX)

      7. Ferrex (FRX) News

      FRX

      Ferrex (FRX)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:FRX
      DateTimeSourceHeadlineSymbolCompany
      08/02/201311:03AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:FRXForest Road Acquisition Corp
      07/30/20137:00AMPR Newswire (US)Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published StudyNYSE:FRXForest Road Acquisition Corp
      07/30/20133:10AMZacksPharma & Biotech Stock Outlook - July/Aug 2013 - Industry OutlookNYSE:FRXForest Road Acquisition Corp
      07/30/20133:10AMZacksPharma & Biotech Stock Outlook - July/Aug 2013 - Zacks Analyst InterviewsNYSE:FRXForest Road Acquisition Corp
      07/29/20138:00AMPR Newswire (US)Seeking Growth Opportunities through Understanding Market Trends, Strengthened R&D, and Global Expansion - Research Report on...NYSE:FRXForest Road Acquisition Corp
      07/26/20134:15PMBusiness WireADDING MULTIMEDIA: Forest Laboratories & Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of...NYSE:FRXForest Road Acquisition Corp
      07/26/20134:15PMBusiness WireADDING MULTIMEDIA: Forest Laboratories & Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of...NYSE:FRXForest Road Acquisition Corp
      07/26/20132:00AMBusiness WireForest Laboratories & Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of Major Depressive Dis...NYSE:FRXForest Road Acquisition Corp
      07/26/20132:00AMBusiness WireForest Laboratories & Pierre Fabre Laboratories Announce FDA Approval of FETZIMA™ for the Treatment of Major Depressive Dis...NYSE:FRXForest Road Acquisition Corp
      07/23/20139:52AMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NYSE:FRXForest Road Acquisition Corp
      07/23/20139:52AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:FRXForest Road Acquisition Corp
      07/23/20137:00AMBusiness WireForest Laboratories, Inc. Reports Fiscal Year First Quarter 2014 Diluted Earnings Per Share of $0.09 Including Effect of $0.0...NYSE:FRXForest Road Acquisition Corp
      07/23/20137:00AMBusiness WireForest Laboratories, Inc. Reports Fiscal Year First Quarter 2014 Diluted Earnings Per Share of $0.09 Including Effect of $0.0...NYSE:FRXForest Road Acquisition Corp
      07/22/201312:10PMEdgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NYSE:FRXForest Road Acquisition Corp
      07/22/201312:09PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:FRXForest Road Acquisition Corp
      07/22/20138:00AMBusiness WireForest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC® Patent LitigationNYSE:FRXForest Road Acquisition Corp
      07/22/20138:00AMBusiness WireForest Laboratories, Inc. Announces Additional Settlement Agreement in BYSTOLIC® Patent LitigationNYSE:FRXForest Road Acquisition Corp
      07/17/20137:00AMPR Newswire (US)Trevena Granted Key Composition of Matter Patent for TRV027 in U.S.NYSE:FRXForest Road Acquisition Corp
      07/08/20135:20PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:FRXForest Road Acquisition Corp
      07/01/20138:53AMBusiness WireForest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 First Quarter EarningsNYSE:FRXForest Road Acquisition Corp
      07/01/20138:53AMBusiness WireForest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 First Quarter EarningsNYSE:FRXForest Road Acquisition Corp
      06/27/20138:00AMBusiness WireForest Laboratories Announces Positive Phase III Study Results for Nebivolol and Valsartan Combination in HypertensionNYSE:FRXForest Road Acquisition Corp
      06/27/20138:00AMBusiness WireForest Laboratories Announces Positive Phase III Study Results for Nebivolol and Valsartan Combination in HypertensionNYSE:FRXForest Road Acquisition Corp
      06/20/20133:16PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:FRXForest Road Acquisition Corp
      06/13/20131:23PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:FRXForest Road Acquisition Corp
      06/13/20138:00AMBusiness WireForest Announces U.S. Availability of New Once-Daily NAMENDA XRNYSE:FRXForest Road Acquisition Corp
      06/13/20138:00AMBusiness WireForest Announces U.S. Availability of New Once-Daily NAMENDA XRNYSE:FRXForest Road Acquisition Corp
      06/11/20135:01PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:FRXForest Road Acquisition Corp
      06/11/20134:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:FRXForest Road Acquisition Corp
      06/11/20134:03PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:FRXForest Road Acquisition Corp
       Showing the most relevant articles for your search:NYSE:FRX